Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marije B Overdijk

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Veterinary Immunology and Immunopathology|June 11, 2005
Cytokine gene expression profiles of bovine dendritic cells after interaction with Mycobacterium avium ssp. paratuberculosis (M.a.p.), Escherichia coli (E. coli) or recombinant M.a.p. heat shock protein 70Merel F M Langelaar, Corinna N Weber, Marije B Overdijk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2012
Crosstalk between human IgG isotypes and murine effector cellsMarije B Overdijk, Sandra Verploegen, Antonio Ortiz Buijsse, et al.
Blood Advances|April 22, 2021
Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myelomaHilma J van der Horst, Anne T Gelderloos, Martine E D Chamuleau, et al.
Cancer Research|September 2, 2008
Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignanciesRichard W J Groen, Monique E C M Oud, Esther J M Schilder-Tol, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2016
The Therapeutic CD38 Monoclonal Antibody Daratumumab Induces Programmed Cell Death via Fcγ Receptor-Mediated Cross-LinkingMarije B Overdijk, J H Marco Jansen, Maaike Nederend, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2011
Epidermal growth factor receptor (EGFR) antibody-induced antibody-dependent cellular cytotoxicity plays a prominent role in inhibiting tumorigenesis, even of tumor cells insensitive to EGFR signaling inhibitionMarije B Overdijk, Sandra Verploegen, Jeroen H van den Brakel, et al.
Journal of Oncology|January 17, 2022
Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer CellsMandy Gruijs, Rens Braster, Marije B Overdijk, et al.
Mabs|March 12, 2015
Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myelomaMarije B Overdijk, Sandra Verploegen, Marijn Bögels, et al.
Haematologica|August 11, 2011
N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiationRichard W J Groen, Martin F M de Rooij, Kinga A Kocemba, et al.
Neoplasia (New York, N.Y.)|April 13, 2012
Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expressionStefanie Derer, Sven Berger, Martin Schlaeth, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Veterinary Immunology and Immunopathology|June 11, 2005
Cytokine gene expression profiles of bovine dendritic cells after interaction with Mycobacterium avium ssp. paratuberculosis (M.a.p.), Escherichia coli (E. coli) or recombinant M.a.p. heat shock protein 70Merel F M Langelaar, Corinna N Weber, Marije B Overdijk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2012
Crosstalk between human IgG isotypes and murine effector cellsMarije B Overdijk, Sandra Verploegen, Antonio Ortiz Buijsse, et al.
Blood Advances|April 22, 2021
Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myelomaHilma J van der Horst, Anne T Gelderloos, Martine E D Chamuleau, et al.
Cancer Research|September 2, 2008
Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignanciesRichard W J Groen, Monique E C M Oud, Esther J M Schilder-Tol, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2016
The Therapeutic CD38 Monoclonal Antibody Daratumumab Induces Programmed Cell Death via Fcγ Receptor-Mediated Cross-LinkingMarije B Overdijk, J H Marco Jansen, Maaike Nederend, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2011
Epidermal growth factor receptor (EGFR) antibody-induced antibody-dependent cellular cytotoxicity plays a prominent role in inhibiting tumorigenesis, even of tumor cells insensitive to EGFR signaling inhibitionMarije B Overdijk, Sandra Verploegen, Jeroen H van den Brakel, et al.
Journal of Oncology|January 17, 2022
Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer CellsMandy Gruijs, Rens Braster, Marije B Overdijk, et al.
Mabs|March 12, 2015
Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myelomaMarije B Overdijk, Sandra Verploegen, Marijn Bögels, et al.
Haematologica|August 11, 2011
N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiationRichard W J Groen, Martin F M de Rooij, Kinga A Kocemba, et al.
Neoplasia (New York, N.Y.)|April 13, 2012
Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expressionStefanie Derer, Sven Berger, Martin Schlaeth, et al.
Pageof 2